ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Bioporto A/s

Bioporto A/s (0JJM)

3,20
0,00
(0,00%)
Geschlossen 23 November 5:30PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
3,20
Gebot
0,00
Fragen
0,00
Volumen
0,00
0,00 Tagesbereich 0,00
3,20 52-Wochen-Bereich 3,20
Marktkapitalisierung
Handelsende
3,20
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.075
Ausgegebene Aktien
379.670.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-21,56
Gewinn pro Aktie (EPS)
-0,15
Erlöse
30,96M
Nettogewinn
-56,33M

Über Bioporto A/s

Sektor
Biological Pds,ex Diagnstics
Branche
Biotechnology Animal & Plant
Hauptsitz
Hellerup, Dnk
Gegründet
2004
Bioporto A/s is listed in the Biological Pds,ex Diagnstics sector of the Londoner Börse with ticker 0JJM. The last closing price for Bioporto A/s was kr3,20. Over the last year, Bioporto A/s shares have traded in a share price range of kr 3,20 to kr 3,20.

Bioporto A/s currently has 379.670.000 shares in issue. The market capitalisation of Bioporto A/s is kr1,21 billion. Bioporto A/s has a price to earnings ratio (PE ratio) of -21.56.

0JJM Neueste Nachrichten

BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024

BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 November 14, 2024Announcement no. 22 BioPorto Announces Interim Results and Business...

Notice convening the Annual General Meeting in BioPorto A/S

Notice convening the Annual General Meeting in BioPorto A/S April 4, 2024Announcement no. 6 Notice convening the Annual General Meeting in BioPorto A/S The Board of Directors hereby convenes the...

BioPorto implements changes to the Executive Management.

BioPorto implements changes to the Executive Management.  January 9, 2024 Announcement no. 01 BioPorto implements changes to the Executive Management. COPENHAGEN, DENMARK and BOSTON, MA...

Managers’ transactions

Managers’ transactions June 28, 2023Announcement no. 13 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in company announcement no. 12...

BioPorto A/S announces completion of rights issue; total number of shares and voting rights

BioPorto A/S announces completion of rights issue; total number of shares and voting rights June 23, 2023Announcement no. 12 BioPorto A/S announces completion of rights issue; total number...

BioPorto A/S announces results of rights issue

BioPorto A/S announces results of rights issue June 21, 2023Announcement no. 11 BioPorto A/S announces results of rights issue COPENHAGEN, Denmark and BOSTON, MA, USA, June 21, 2023, (GLOBE...

BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments

BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million...

Notice convening the Annual General Meeting in BioPorto A/S

Notice convening the Annual General Meeting in BioPorto A/S April 5, 2023Announcement no. 5 Notice convening the Annual General Meeting in BioPorto A/S The Board of Directors hereby convenes...

NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING

NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING   November 1, 2022 Announcement no. 14 NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING In accordance with Article 5 of the Articles of...

Strong Performance of The NGAL Test Drives Revenue Growth

Strong Performance of The NGAL Test Drives Revenue Growth May 11, 2022Announcement no. 11 Strong Performance of The NGAL Test Drives Revenue Growth Revenues totaled DKK 6.5 million in the...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1003.23.23.200DE
4003.23.23.200DE
12003.23.23.210753.2DE
26003.23.23.220273.2DE
52003.23.23.228253.2DE
156003.23.23.222303.2DE
260003.23.23.220973.2DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SCGLSealand Capital Galaxy Limited
0,21p
(50,00%)
219,35M
PPSProton Motor Power Systems Plc
0,175p
(40,00%)
3,79M
PXCPhoenix Copper Limited
7,00p
(37,25%)
5,13M
SLFRSlf Realisation Fund Limited
1,49p
(29,57%)
827,89k
NWORNational World Plc
19,00p
(26,67%)
2,74M
WEBWebis Holdings Plc
0,125p
(-68,75%)
28,06M
HEMOHemogenyx Pharmaceuticals Plc
1,15p
(-24,59%)
102,87M
AMGOAmigo Holdings Plc
0,525p
(-16,67%)
15,73M
PLAZPlaza Centers N.v.
25,00p
(-16,67%)
2k
AURRAurrigo International Plc
52,50p
(-15,32%)
66,25k
NTVONativo Resources Plc
0,0026p
(13,04%)
4,92B
CPXCap-xx Limited
0,14p
(9,80%)
395,59M
NTOGNostra Terra Oil And Gas Company Plc
0,02275p
(-4,21%)
394,31M
VELAVela Technologies Plc
0,007p
(-6,67%)
336,14M
MSMNMosman Oil And Gas Limited
0,0395p
(-3,66%)
314,18M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock